AUTL
Autolus Therapeutics
AUTL
AUTL
50 hedge funds and large institutions have $230M invested in Autolus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.27M | |
| 2 | +$2.68M | |
| 3 | +$1.97M | |
| 4 |
Morgan Stanley
New York
|
+$1.45M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$962K |
Top Sellers
| 1 | -$9.23M | |
| 2 | -$7.59M | |
| 3 | -$4.96M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$4.13M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.49M |